Ebola Vaccine Trial - update


The CBF has finished the importation, labelling and certification of the cAd3 ebola vaccine. The trial was fast tracked by the MHRA and ethics committee in record time, allowing the Phase I trial lead by Prof Adrian Hill from the Jenner Institute to begin today. We delivered the adenovirus vaccine to the clinical trial site this morning and the first of 60 volunteers is vaccinated today.

Please see the Nuffield Department of Medicine article for a news roundup.